Core Laboratories Inc. (CLB)
NYSE: CLB · Real-Time Price · USD
11.85
+0.24 (2.07%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Core Laboratories Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Core Laboratories stock have an average target of 15.75, with a low estimate of 15 and a high estimate of 17. The average target predicts an increase of 32.91% from the current stock price of 11.85.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Core Laboratories stock from 4 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
---|---|---|---|---|---|---|
Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 2 | 2 | 2 | 2 | 3 | 3 |
Sell | 1 | 1 | 1 | 1 | 1 | 1 |
Strong Sell | 1 | 1 | 1 | 1 | 0 | 0 |
Total | 4 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Stifel | Stifel | Hold Maintains $19 → $15 | Hold | Maintains | $19 → $15 | +26.58% | Apr 15, 2025 |
Citigroup | Citigroup | Strong Sell → Hold Upgrades $15 → $16 | Strong Sell → Hold | Upgrades | $15 → $16 | +35.02% | Mar 12, 2025 |
Citigroup | Citigroup | Strong Sell Maintains $14 → $15 | Strong Sell | Maintains | $14 → $15 | +26.58% | Feb 20, 2025 |
Citigroup | Citigroup | Strong Sell Maintains $15 → $14 | Strong Sell | Maintains | $15 → $14 | +18.14% | Oct 31, 2024 |
Stifel | Stifel | Hold Maintains $18 → $22 | Hold | Maintains | $18 → $22 | +85.65% | Jul 26, 2024 |
Financial Forecast
Revenue This Year
542.84M
from 523.85M
Increased by 3.63%
Revenue Next Year
561.26M
from 542.84M
Increased by 3.39%
EPS This Year
0.82
from 0.66
Increased by 24.54%
EPS Next Year
0.97
from 0.82
Increased by 18.31%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 608.5M | 609.5M | 623.7M | ||
Avg | 542.8M | 561.3M | 599.9M | ||
Low | 510.2M | 517.7M | 582.1M |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 16.2% | 12.3% | 11.1% | ||
Avg | 3.6% | 3.4% | 6.9% | ||
Low | -2.6% | -4.6% | 3.7% |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 0.99 | 1.14 | 1.20 | ||
Avg | 0.82 | 0.97 | 1.15 | ||
Low | 0.62 | 0.84 | 1.11 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 49.5% | 38.3% | 23.7% | ||
Avg | 24.5% | 18.3% | 18.2% | ||
Low | -6.5% | 2.5% | 13.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.